COMMUNIQUÉS West-GlobeNewswire

Targovax ASA: Annual Report 2017
15/03/2018
On 14 March 2018, the board of directors of Targovax ASA approved the company's financial statements for 2017, which will be dealt with by the Company's annual general meeting on 11 April 2018. The company's annual [...]
Sanofi successfully prices EUR 8 billion of bond issues
15/03/2018
Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi successfully prices EUR 8 billion of bond issues Paris, France - March 15, 2018 - Sanofi has successfully priced its offering of EUR 8 billion of notes ( [...]
Sanofi place des emprunts obligataires de 8 milliards d'euros
15/03/2018
Communiqué de presse Source : Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi place des emprunts obligataires de 8 milliards d'euros Paris (France) - Le 15 mars 2018 - Sanofi a placé avec succès des émissions obligataires en [...]
Innate Pharma to present broad and innovative portfolio in immuno-oncology at AACR 2018
15/03/2018
Innate Pharma to present broad and innovative portfolio in immuno-oncology at ACCR 2018 First clinical activity data of the combination of monalizumab and cetuximab New preclinical data further supporting the rationale [...]
ABLYNX ANNOUNCES WARRANT EXERCISE
15/03/2018
REGULATED INFORMATION GHENT, Belgium, 15 March 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in conformity with Title II of the Law of 2 May 2007 and the Royal Decree of 14 February 2008, that an [...]
AACR 2018 : Innate Pharma présente un portefeuille large et innovant en immuno-oncologie
15/03/2018
AACR 2018 : INNATE PHARMA PRÉSENTE UN PORTEFEUILLE LARGE ET INNOVANT EN IMMUNO-ONCOLOGIE Premières données d'activité clinique pour monalizumab en combinaison avec cetuximab Nouvelles données précliniques soutenant le [...]
Targovax ASA: Notice of Annual General Meeting
15/03/2018
The Annual General Meeting of Targovax ASA will be held at the Company's offices at Lysaker, on 11 April 2018 at 10:00 CET. Please find the notice including agenda for the General Meeting and appendices attached to this [...]
Biocartis Abstract on Performance Idylla(TM) ctRAS Liquid Biopsy Tests Selected for Oral Presentation at 2018 American Association for Cancer Research Meeting
15/03/2018
PRESS RELEASE : Thursday, 15 March 2018, 07:00 CET Biocartis Abstract on Performance Idylla(TM) ctRAS Liquid Biopsy Tests Selected for Oral Presentation at 2018 American Association for Cancer Research Meeting Mechelen [...]
VIFOR PHARMA GROUP REPORTS STRONG 2017 RESULTS, EXCEEDING RAISED GUIDANCE
15/03/2018
In 2017 vifor pharma recorded a strong financial performance driven by its three medium-term strategic growth-drivers and the successful divesTiture of its non-core wholesale/retail PHARMACY business via an IPO. the [...]
Sorrento Therapeutics to Present at the 28th Annual Oppenheimer Conference (NY) on 03/20/18
15/03/2018
SAN DIEGO, March 14, 2018 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE ) ("Sorrento"), announced today that it will present at the Oppenheimer 28 th annual conference on 03/20/18 at 2:45 PM EST (Westin [...]
Genesis to Present at the Barclays Global Healthcare Conference on March 15, 2018; Expects to Release Fourth Quarter and Year End 2017 Results on March 16, 2018
15/03/2018
KENNETT SQUARE, Pa., March 14, 2018 (GLOBE NEWSWIRE) -- Genesis HealthCare (NYSE: GEN ) (Genesis or the Company), one of the nation’s largest providers of post-acute care, today announced that George V. Hager, Jr., [...]
Telix Pharmaceuticals and Radboud University Medical Centre Conclude Clinical Collaboration Agreement
15/03/2018
MELBOURNE, Australia and NIJMEGAN, The Netherlands, March 15, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company focused on the [...]
Proteostasis Therapeutics Reports Fourth Quarter and Year-End 2017 Financial Results and Provides Business Update
14/03/2018
14-day Study of PTI-801, Company’s Third Generation Corrector, in CF Patients on Background Orkambi ® Enrolling Ahead of Schedule; Results from All Three Cohorts Expected Q2'18 Company Announces Additional Study of PTI- [...]
Leap Therapeutics Provides DKN-01 Program Update and Announces Scientific Presentations at AACR Annual Meeting
14/03/2018
CAMBRIDGE, Mass., March 14, 2018 (GLOBE NEWSWIRE) -- Leap Therapeutics, Inc. (NASDAQ: LPTX ), a biotechnology company developing targeted and immuno-oncology therapeutics, today presented promising clinical data from [...]
NewLink Genetics Announces Presentation of Abstracts at AACR Annual Meeting
14/03/2018
AMES, Iowa, March 14, 2018 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ: NLNK ) today reported that two abstracts pertaining to the company's indoximod program will be presented at the American Association [...]
TESARO Announces Data Presentations at the 2018 American Association for Cancer Research Annual Meeting
14/03/2018
WALTHAM, Mass., March 14, 2018 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ: TSRO ), an oncology-focused biopharmaceutical company, today announced that data for ZEJULA, TSR-042 (anti-PD-1 antibody) and the company’s immuno [...]
Solid Biosciences Announces Clinical Hold On SGT-001 Phase I/II Clinical Trial For Duchenne Muscular Dystrophy
14/03/2018
CAMBRIDGE, Mass., March 14, 2018 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (NASDAQ: SLDB ) today announced it has received notification from the U.S. Food and Drug Administration (FDA) that IGNITE DMD, its Phase I/II [...]
Aduro Biotech Announces Upcoming Data Presentations at the 2018 American Association for Cancer Research Annual Meeting
14/03/2018
BERKELEY, Calif., March 14, 2018 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (Nasdaq: ADRO ), today announced three preclinical data presentations highlighting its STING and antibody product candidates will be delivered at [...]
Proteostasis Therapeutics Announces FDA Grants Orphan Drug Designation for PTI-428 in Cystic Fibrosis
14/03/2018
CAMBRIDGE, Mass., March 14, 2018 (GLOBE NEWSWIRE) -- Proteostasis Therapeutics, Inc. (NASDAQ: PTI ), a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to [...]

Pages